<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.massachusettsweekly.com/article/908757821-united-planet-launches-volunteer-abroad-opportunity-in-morocco-for-global-changemakers</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T15:13:21+00:00</news:publication_date>
        <news:title>United Planet Launches Volunteer Abroad Opportunity in Morocco for Global Changemakers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842741-morocco-1-1024x768.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908751426-q2i-honored-as-gold-stevie-award-winner-in-2026-american-business-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:59:12+00:00</news:publication_date>
        <news:title>Q2i Honored as Gold Stevie® Award Winner in 2026 American Business Awards®</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842715-q2i-932x270.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908748089-2025-nipes-award-winners-second-cycle-winners-for-2025</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:26:16+00:00</news:publication_date>
        <news:title>2025 NIPES Award Winners – Second Cycle Winners for 2025</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22774791-awards-1120x605.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908722640-tessi-announces-founding-advisory-board-with-leaders-from-fema-insurance-and-the-disaster-restoration-industry</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:15:00+00:00</news:publication_date>
        <news:title>Tessi Announces Founding Advisory Board with Leaders from FEMA, Insurance and the Disaster Restoration Industry</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908501093-2-100-students-to-compete-for-skillsusa-massachusetts-medals</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:05:03+00:00</news:publication_date>
        <news:title>2,100 STUDENTS TO COMPETE FOR SkillsUSA MASSACHUSETTS MEDALS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/20406889-skillsusa-massachusetts-logo-831x524.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908130623-bookcovers-pro-launches-ai-print-book-cover-generator-for-kdp-and-ingramspark</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T13:00:00+00:00</news:publication_date>
        <news:title>BookCovers.pro Launches AI Print Book Cover Generator for KDP and IngramSpark</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841008-bookcovers-pro-hp-8-20260425190-2400x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908461993-scipher-medicine-s-prismra-further-validated-in-trial-demonstrating-improved-outcomes-for-hispanic-ra-patients</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T13:00:00+00:00</news:publication_date>
        <news:title>Scipher Medicine’s PrismRA Further Validated In Trial Demonstrating Improved Outcomes For Hispanic RA Patients </news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907404564-qic-house-cannabis-launches-in-massachusetts-centering-lgbtqia-and-chicano-voices-in-a-new-era-of-cannabis</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:30:00+00:00</news:publication_date>
        <news:title>QIC House Cannabis Launches in Massachusetts, Centering LGBTQIA+ and Chicano Voices in a New Era of Cannabis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24839402-qic-stix-3000x3000.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/906144974-pension-wealth-management-advisors-included-on-usa-today-s-best-financial-advisory-firms-2026-list</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>Pension &amp; Wealth Management Advisors Included on USA TODAY’s Best Financial Advisory Firms 2026 List</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907770526-jumpstart-celebrates-20-years-of-read-for-the-record</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:45:00+00:00</news:publication_date>
        <news:title>Jumpstart Celebrates 20 Years of Read for the Record</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840487-jumpstart-300x76.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/905527250-pb-s-mores-are-bunking-up-unreal-snacks-launches-first-of-its-kind-s-mores-kit-featuring-its-iconic-peanut-butter-cup</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T09:00:00+00:00</news:publication_date>
        <news:title>PB &amp; S&#39;mores are Bunking Up: Unreal Snacks Launches First-of-Its-Kind S’mores Kit Featuring its Iconic Peanut Butter Cup</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831706-smores-with-product-3000x2001.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908633665-boston-s-buyers-brokers-only-celebrates-naeba-s-30-year-gold-standard-in-buyer-representation</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T06:30:00+00:00</news:publication_date>
        <news:title>Boston’s Buyers Brokers Only Celebrates NAEBA’s 30-Year &quot;Gold Standard&quot; in Buyer Representation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24778459-naeba-celebration-logo-2000x1545.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908761308-community-boating-inc-celebrates-80th-anniversary-with-first-ever-24-hour-sail-a-thon</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:59:06+00:00</news:publication_date>
        <news:title>Community Boating Inc. Celebrates 80th Anniversary with First Ever 24-Hour Sail-a-thon</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/02712674-fdfd-4eef-8f78-ebaa989781f9/small/community-boating-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908754163-sportradar-group-ag-investigated-for-securities-fraud-block-leviton-encourages-investors-who-have-lost-money-to-contact-the-firm</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:22:18+00:00</news:publication_date>
        <news:title>Sportradar Group AG Investigated For Securities Fraud; Block &amp; Leviton Encourages Investors Who Have Lost Money to Contact the Firm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908754160-erasca-inc-investigated-for-securities-fraud-block-leviton-encourages-investors-to-contact-the-firm-to-possibly-recover-losses</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:17:11+00:00</news:publication_date>
        <news:title>Erasca, Inc. Investigated For Securities Fraud; Block &amp; Leviton Encourages Investors to Contact the Firm to Possibly Recover Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908746463-paytronix-releases-rewards-hub-innovative-revamp-of-platform-delivers-greater-agility-visibility</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:00:00+00:00</news:publication_date>
        <news:title>Paytronix Releases Rewards Hub; Innovative Revamp of Platform Delivers Greater Agility, Visibility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0a47d40-4419-436d-b187-246e25669b64/small/access-paytronix-dark-002-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908746501-acquia-recognizes-2026-engage-award-winners-for-digital-excellence</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T14:00:00+00:00</news:publication_date>
        <news:title>Acquia Recognizes 2026 Engage Award Winners for Digital Excellence</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b7cbd5b8-edd2-4291-bbf6-306a92ed650f/small/acquia-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908733124-quickbase-introduces-pave-a-full-stack-ai-app-builder-for-the-enterprise</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T13:00:00+00:00</news:publication_date>
        <news:title>Quickbase Introduces Pave, a Full-Stack AI App Builder for the Enterprise</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/348bbc98-87d0-4dbd-8ee3-749e93775583/small/quickbase-logo-fullcolor-dune-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908733958-alira-health-joins-pfmd-effort-to-advance-patient-centered-evidence-generation</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T13:00:00+00:00</news:publication_date>
        <news:title>Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7422063-e642-4a37-86e3-d85294a19d12/small/alirahealth-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908733123-thrive-appoints-matt-kosovsky-as-chief-financial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:30:00+00:00</news:publication_date>
        <news:title>Thrive Appoints Matt Kosovsky as Chief Financial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fcaf797c-9107-49f6-bd64-eeb1f1ad37b1/small/thrive-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908726358-ai-disruption-in-advanced-materials-for-extreme-environments-attracts-262-million-in-strategic-investments</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:25:11+00:00</news:publication_date>
        <news:title>AI Disruption in Advanced Materials for Extreme Environments Attracts $262 Million+ in Strategic Investments</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908725671-acquia-announces-significant-updates-to-acquia-source-and-launches-acquia-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>Acquia Announces Significant Updates to Acquia Source and Launches Acquia AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b7cbd5b8-edd2-4291-bbf6-306a92ed650f/small/acquia-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908725874-camp4-therapeutics-preprints-pioneering-study-on-regulatory-rna-profiling-and-gene-upregulation</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908725949-solid-biosciences-announces-receipt-of-european-commission-orphan-drug-designation-for-sgt-003-for-the-treatment-of-duchenne-muscular-dystrophy</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908725972-kestrel-therapeutics-announces-first-patient-dosed-in-the-phase-1-clinical-trial-of-kst-6051-a-potential-best-in-class-pan-kras-inhibitor-in</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/984247bf-62b9-44d2-bf52-61115ea6e446/small/kestrel-logo-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908725980-ahold-delhaize-usa-expands-digital-commerce-capabilities-with-smartcommerce-click2cart</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>Ahold Delhaize USA Expands Digital Commerce Capabilities with SmartCommerce Click2Cart®</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3a4e4cf5-c320-4525-b35c-97cf53979132/medium/adusa-smartcommerce-integration-drives-omnichannel-growth.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908726035-vistashares-ai-infrastructure-etf-ais-a-top-performer-in-its-morningstar-category-passes-350-million-in-assets</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>VistaShares’ AI Infrastructure ETF (AIS) a Top Performer in Its Morningstar Category, Passes $350 Million in Assets</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7364a55a-8e5d-42dd-9ac2-11e625fbb659/small/picture1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908726334-cynet-launches-new-capabilities-for-cyai-engine-that-improves-itself-over-time</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T12:00:00+00:00</news:publication_date>
        <news:title>Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/41b0669e-e65b-448b-9a2f-4140d51fa2cd/small/cynet-logo-2c-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719669-anaqua-bernimmt-patrix-um-seine-f-hrungsposition-im-bereich-ip-management-auszubauen</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua übernimmt Patrix, um seine Führungsposition im Bereich IP-Management auszubauen</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719674-anaqua-adquiere-patrix-para-expandir-su-liderazgo-en-gesti-n-de-pi</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua adquiere Patrix para expandir su liderazgo en gestión de PI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719676-anaqua-acquiert-patrix-en-vue-de-renforcer-son-leadership-dans-la-gestion-de-la-propri-t-intellectuelle</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua acquiert Patrix en vue de renforcer son leadership dans la gestion de la propriété intellectuelle</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719680</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>アナクア、パトリックスを買収し知的財産管理におけるリーダーシップを拡大</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719684-anaqua-ip-patrix</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua, IP관리 주요 기업인 Patrix 인수로 지식재산 관리 분야에서 리더십 확대</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719691-anaqua-patrix-ip</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua 收购 Patrix，扩大其在 IP 管理领域的领导地位</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719695</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>אנאקווה רוכשת את פטריקס כדי להרחיב את מנהיגותה בניהול קניין רוחני</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719700-anaqua-adquire-patrix-para-expandir-sua-lideran-a-em-gerenciamento-de-pi</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua Adquire Patrix para Expandir Sua Liderança em Gerenciamento de PI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719702-anaqua-patrix</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:53:48+00:00</news:publication_date>
        <news:title>Anaqua 收購 Patrix，拓展其在知識產權管理方面的領導地位</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719193-consumer-interest-in-crypto-apps-falls-to-lowest-levels-since-trump-s-second-inauguration</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:30:00+00:00</news:publication_date>
        <news:title>Consumer Interest in Crypto Apps Falls to Lowest Levels Since Trump’s Second Inauguration</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6195e18b-4315-4c8d-8c83-f1338959b041/small/apptopia-logos-logo-full-color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719252-harvard-bioscience-schedules-first-quarter-2026-earnings-conference-call-for-may-12-2026-at-8-00-am-et</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:30:00+00:00</news:publication_date>
        <news:title>Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6784a4a6-c259-489c-8b5b-05266f41b06f/small/hbio-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908719390-wave-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:30:00+00:00</news:publication_date>
        <news:title>Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908712828-uniqure-to-announce-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:05:00+00:00</news:publication_date>
        <news:title>uniQure to Announce First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908712891-ocular-therapeutix-to-report-first-quarter-2026-financial-results-on-may-5-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:00:00+00:00</news:publication_date>
        <news:title>Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908713037-unicom-engineering-and-fourier-cooling-collaborate-to-deliver-cooling-defined-modular-ai-data-center-infrastructure</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:00:00+00:00</news:publication_date>
        <news:title>UNICOM Engineering and Fourier Cooling Collaborate to Deliver Cooling‑Defined Modular AI Data Center Infrastructure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fc2113f-1bb6-4edf-993a-af442647b93a/small/unicom-engineering-3c-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908713063-climb-bio-inc-announces-110-0-million-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio, Inc. Announces $110.0 Million Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908713095-earned-signs-top-mlb-prospect-angel-genao-as-brand-ambassador</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T11:00:00+00:00</news:publication_date>
        <news:title>EARNED Signs Top MLB Prospect Angel Genao as Brand Ambassador</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e2e752b8-d222-4b5f-9a9e-6abb3be9352d/medium/angel-genao-earned-brand-ambassador.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908706586-security-leaders-cite-ai-as-a-risk-multiplier-for-apis-in-new-akamai-survey</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T10:28:00+00:00</news:publication_date>
        <news:title>Security Leaders Cite AI as a Risk Multiplier for APIs in New Akamai Survey</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4ce7685a-3da0-416d-9bc1-58cc8b7812b8/small/akamai-logo-color-rgb-bluenavy-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908547758-peo4you-integrates-medical-debt-relief-contributions-into-benefits-consulting-business-model</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T21:33:10+00:00</news:publication_date>
        <news:title>PEO4YOU Integrates Medical Debt Relief Contributions Into Benefits Consulting Business Model</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842103-peo4you-medical-debt-relief-ini-1200x630.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908678537-anaqua-acquires-patrix-to-expand-its-ip-management-leadership</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-28T08:00:00+00:00</news:publication_date>
        <news:title>Anaqua Acquires Patrix to Expand Its IP Management Leadership</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/93bf2cd3-dfb8-4753-8719-3d389eed2845/small/logo-anaqua-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/907589370-apstron-science-introduces-patent-pending-physiowatch-for-continuous-physiological-monitoring</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T17:15:00+00:00</news:publication_date>
        <news:title>ApsTron Science Introduces Patent-Pending PhysioWatch™ for Continuous Physiological Monitoring</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24839836-physiowatch-tm-532x761.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908490326-adaptive-sports-new-england-receives-30-000-grant-from-the-hartford</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T17:05:19+00:00</news:publication_date>
        <news:title>Adaptive Sports New England Receives $30,000 Grant From The Hartford</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841780-new-england-adaptive-sports-4096x3774.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908468386-varstreet-now-supports-scim-based-user-provisioning-with-microsoft-entra-id</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T15:10:52+00:00</news:publication_date>
        <news:title>VARStreet Now Supports SCIM-Based User Provisioning with Microsoft Entra ID</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/743488-varstreet-logo-2000x2000.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908356600-respiratory-care-professor-medtech-co-founder-presents-novel-neonate-breathing-technology-at-pas-meeting-in-boston</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:38:39+00:00</news:publication_date>
        <news:title>Respiratory Care Professor, MedTech Co-Founder Presents Novel Neonate Breathing Technology at PAS Meeting in Boston</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24201100-brian-walsh-phd-chairman-of-t-1023x1160.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908551219-elevatebio-to-present-nine-abstracts-showcasing-advancements-across-its-gene-editing-platform-at-the-american-society-of-gene-and-cell-therapy-asgct</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T21:00:00+00:00</news:publication_date>
        <news:title>ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/42238eb2-fd1c-4189-bf14-c7026687de5b/small/elevatebiologo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908551243-arbor-biotechnologies-to-present-expansion-of-cns-editing-platform-capabilities-at-the-american-society-of-gene-and-cell-therapy-asgct-29th-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T21:00:00+00:00</news:publication_date>
        <news:title>Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/68842426-d5ae-4dd2-800a-89d80ad4b3b7/small/arbor-biotech-logo-web-3-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543554-tessera-therapeutics-to-present-new-preclinical-data-supporting-in-vivo-program-in-sickle-cell-disease-and-advancements-in-in-vivo-car-t-applications</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:46:54+00:00</news:publication_date>
        <news:title>Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f24875fb-efec-43e6-8b98-2da3edea398a/small/picture1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543724-ses-lawsuit-ses-ai-corp-sued-for-securities-fraud-investors-should-contact-block-leviton-to-possibly-recover-losses</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:44:36+00:00</news:publication_date>
        <news:title>SES LAWSUIT: SES AI Corp. Sued for Securities Fraud; Investors Should Contact Block &amp; Leviton to Possibly Recover Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543546-dyne-therapeutics-announces-upcoming-presentation-highlighting-robust-cns-activity-in-nonhuman-primates-with-its-force-platform-at-2026-asgct-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:34:05+00:00</news:publication_date>
        <news:title>Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543347-voyager-iv-delivered-cns-gene-therapies-featured-in-multiple-presentations-at-asgct-2026-including-late-breaker-on-tau-targeted-vy1706-for</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:31:00+00:00</news:publication_date>
        <news:title>Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543485-editas-medicine-to-present-new-preclinical-data-demonstrating-progress-of-edit-401-as-potential-treatment-for-hyperlipidemia-at-upcoming-scientific</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:31:00+00:00</news:publication_date>
        <news:title>Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543385-rgenta-therapeutics-announces-two-oral-presentations-highlighting-proprietary-rswitch-technology-at-the-american-society-of-gene-and-cell-therapy</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:30:00+00:00</news:publication_date>
        <news:title>Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543418-tscan-therapeutics-announces-upcoming-presentation-at-the-american-society-of-gene-and-cell-therapy-29th-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:30:00+00:00</news:publication_date>
        <news:title>TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8d2632e-0ce4-4ed2-940e-22a1c599d43f/small/tscan-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908543483-beta-bionics-to-present-at-the-bank-of-america-securities-health-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:25:00+00:00</news:publication_date>
        <news:title>Beta Bionics to Present at the Bank of America Securities Health Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/88df4d95-789c-467a-8481-f67e19e1adfa/small/beta-bionics-logo-2color-1200-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908535777-northeast-bank-reports-third-quarter-results-and-declares-dividend</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:16:00+00:00</news:publication_date>
        <news:title>Northeast Bank Reports Third Quarter Results and Declares Dividend</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ec44d25b-c247-4d5d-9264-10fb03e30aa8/small/nebank-cmyk-transparent-sm-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908535446-intellia-announces-proposed-public-offering-of-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T20:01:00+00:00</news:publication_date>
        <news:title>Intellia Announces Proposed Public Offering of Common Stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908519740-poet-technologies-inc-investors-should-contact-block-leviton-to-find-out-how-they-might-recover-losses-through-the-firm-s-investigation</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T18:46:10+00:00</news:publication_date>
        <news:title>POET Technologies Inc. Investors Should Contact Block &amp; Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908505217-ai-disruption-in-lung-cancer-therapeutics-set-to-transform-treatment-paradigms-as-billion-dollar-investments-drive-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T17:36:49+00:00</news:publication_date>
        <news:title>AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908368739-choosing-a-global-high-purity-fluorinated-building-blocks-vendor-for-modern-labs-aifchem</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T05:08:32+00:00</news:publication_date>
        <news:title>Choosing a Global High-Purity Fluorinated Building Blocks Vendor for Modern Labs: AiFChem</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841275-high-purity-fluorinated-buildin-1116x746.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908368419-strategic-advantages-of-partnering-with-a-global-high-purity-heterocyclic-building-blocks-supplier-aifchem</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T05:08:09+00:00</news:publication_date>
        <news:title>Strategic Advantages of Partnering with a Global High-Purity Heterocyclic Building Blocks Supplier: AiFChem</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841273-global-high-purity-heterocyclic-757x600.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908485953-macom-to-enter-into-agreements-to-further-strengthen-supply-chain</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T16:00:29+00:00</news:publication_date>
        <news:title>MACOM to Enter into Agreements to Further Strengthen Supply Chain</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a79ab6f0-6800-4764-913c-aa1e39eb512e/small/macomwrdmrkrgbtag-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908452226-addgene-reinforces-its-expanding-role-in-research-with-new-brand</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T13:30:00+00:00</news:publication_date>
        <news:title>Addgene Reinforces Its Expanding Role in Research with New Brand</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e4b4a6b0-9eac-49c5-852f-53fce9ecf258/small/addgene-logo-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908452232-signnow-launches-docgen-api-to-automate-business-document-creation-and-close-the-gap-between-data-and-signature</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T13:30:00+00:00</news:publication_date>
        <news:title>SignNow Launches Docgen API to Automate Business Document Creation and Close the Gap Between Data and Signature</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aab78b76-7606-4e1a-ac9e-3519885f79d4/medium/docgen-api-by-signnow.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908452251-harvard-apparatus-regenerative-technology-announces-first-patient-treated-with-cellspan-esophageal-implant-at-mayo-clinic</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T13:30:00+00:00</news:publication_date>
        <news:title>Harvard Apparatus Regenerative Technology Announces First Patient Treated with Cellspan Esophageal Implant at Mayo Clinic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/686ae558-8768-4fc3-bdce-87ae3b318dd6/small/hrgn-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908447950-alpha-tau-announces-presentation-of-pancreatic-cancer-data-at-upcoming-asco-annual-meeting-showcasing-combined-results-from-three-alpha-dart</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T13:01:00+00:00</news:publication_date>
        <news:title>Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908443320-akari-therapeutics-secures-australian-patent-approval-further-expanding-global-protection-of-its-proprietary-ph1-rna-splicing-modulator-adc-payload</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T12:35:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908438912-cerence-to-announce-fiscal-second-quarter-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T12:00:00+00:00</news:publication_date>
        <news:title>Cerence to Announce Fiscal Second Quarter Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/873690ee-866c-4dea-9808-10aecc02890f/small/cerence-ai-logo-full-color-h-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908439016-avalyn-strengthens-leadership-team-to-support-long-term-growth-with-appointments-of-industry-leaders-adam-golden-and-frank-salisbury</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T12:00:00+00:00</news:publication_date>
        <news:title>Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908439020-replimune-to-present-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T12:00:00+00:00</news:publication_date>
        <news:title>Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NzU1N2M2NzEtNmRkNS00ODQ0LTg0YmQtZTVjMDZhZTRlNjQ1LTExMjIxMDEtMjAyNi0wNC0yNy1lbg==/tiny/Replimune-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908434376-tovecimig-demonstrates-statistically-significant-benefit-in-companion-002-randomized-phase-2-3-study-in-patients-with-biliary-tract-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:30:00+00:00</news:publication_date>
        <news:title>Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908434378-nima-s-next-gen-portable-gluten-sensor-wins-gold-stevie-award-for-achievement-in-product-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:30:00+00:00</news:publication_date>
        <news:title>NIMA’s Next-Gen Portable Gluten Sensor Wins Gold Stevie® Award for Achievement in Product Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a025c49c-a270-4041-92e3-76d50d9bc27f/medium/nima-is-the-2026-gold-stevie-award-winner.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908429883-fulcrum-therapeutics-announces-recent-business-highlights-and-financial-results-for-first-quarter-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:00:00+00:00</news:publication_date>
        <news:title>Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908429920-sionna-therapeutics-completes-enrollment-in-precision-cf-phase-2a-trial-evaluating-nbd1-stabilizer-sion-719-added-to-standard-of-care-in</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908430156-intellia-therapeutics-reports-positive-phase-3-results-in-hereditary-angioedema-marking-a-global-first-for-in-vivo-gene-editing</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:00:00+00:00</news:publication_date>
        <news:title>Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908430163-intellia-therapeutics-initiates-rolling-submission-of-biologics-license-application-to-fda-for-lonvoguran-ziclumeran-lonvo-z-as-a-one-time-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:00:00+00:00</news:publication_date>
        <news:title>Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908430198-ocular-therapeutix-to-participate-in-may-scientific-and-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T11:00:00+00:00</news:publication_date>
        <news:title>Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908425638-fulcrum-therapeutics-appoints-josh-lehrer-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T10:55:00+00:00</news:publication_date>
        <news:title>Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.massachusettsweekly.com/article/908418144-relay-therapeutics-announces-clinical-data-for-zovegalisib-plus-atirmociclib-triplet-combination-supportive-of-further-development-in-frontline</loc>
      <news:news>
        <news:publication>
          <news:name>Massachusetts Weekly</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-27T10:00:00+00:00</news:publication_date>
        <news:title>Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png</image:loc>
        </image:image>
    </url>
</urlset>
